10670 related articles for article (PubMed ID: 16867222)
1. FGF2 binding, signaling, and angiogenesis are modulated by heparanase in metastatic melanoma cells.
Reiland J; Kempf D; Roy M; Denkins Y; Marchetti D
Neoplasia; 2006 Jul; 8(7):596-606. PubMed ID: 16867222
[TBL] [Abstract][Full Text] [Related]
2. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
[TBL] [Abstract][Full Text] [Related]
3. Dominant-negative CREB inhibits heparanase functionality and melanoma cell invasion.
Aucoin R; Reiland J; Roy M; Marchetti D
J Cell Biochem; 2004 Oct; 93(2):215-23. PubMed ID: 15368349
[TBL] [Abstract][Full Text] [Related]
4. Pro-Angiogenic Effects of Latent Heparanase and Thrombin Receptor-Mediated Pathways-Do They Share a Common Ground in Melanoma Cells?
Hoß SG; Grundmann M; Benkel T; Gockel L; Schwarz S; Kostenis E; Schlesinger M; Ilan N; Vlodavsky I; Bendas G
Thromb Haemost; 2018 Oct; 118(10):1803-1814. PubMed ID: 30235481
[TBL] [Abstract][Full Text] [Related]
5. Heparanase mechanisms of melanoma metastasis to the brain: Development and use of a brain slice model.
Murry BP; Blust BE; Singh A; Foster TP; Marchetti D
J Cell Biochem; 2006 Feb; 97(2):217-25. PubMed ID: 16288472
[TBL] [Abstract][Full Text] [Related]
6. Antisense-mediated suppression of Heparanase gene inhibits melanoma cell invasion.
Roy M; Reiland J; Murry BP; Chouljenko V; Kousoulas KG; Marchetti D
Neoplasia; 2005 Mar; 7(3):253-62. PubMed ID: 15799825
[TBL] [Abstract][Full Text] [Related]
7. Cell surface heparan sulfate released by heparanase promotes melanoma cell migration and angiogenesis.
Roy M; Marchetti D
J Cell Biochem; 2009 Feb; 106(2):200-9. PubMed ID: 19115257
[TBL] [Abstract][Full Text] [Related]
8. HIP/RPL29 antagonizes VEGF and FGF2 stimulated angiogenesis by interfering with HS-dependent responses.
D'Souza S; Yang W; Marchetti D; Muir C; Farach-Carson MC; Carson DD
J Cell Biochem; 2008 Dec; 105(5):1183-93. PubMed ID: 18980226
[TBL] [Abstract][Full Text] [Related]
9. Epac1 increases migration of endothelial cells and melanoma cells via FGF2-mediated paracrine signaling.
Baljinnyam E; Umemura M; Chuang C; De Lorenzo MS; Iwatsubo M; Chen S; Goydos JS; Ishikawa Y; Whitelock JM; Iwatsubo K
Pigment Cell Melanoma Res; 2014 Jul; 27(4):611-20. PubMed ID: 24725364
[TBL] [Abstract][Full Text] [Related]
10. Selective heparanase localization in malignant melanoma.
Murry BP; Greiter-Wilke A; Paulsen DP; Hiatt KM; Beltrami CA; Marchetti D
Int J Oncol; 2005 Feb; 26(2):345-52. PubMed ID: 15645118
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Heparanase in Pediatric Brain Tumor Cells Attenuates their Proliferation, Invasive Capacity, and
Spyrou A; Kundu S; Haseeb L; Yu D; Olofsson T; Dredge K; Hammond E; Barash U; Vlodavsky I; Forsberg-Nilsson K
Mol Cancer Ther; 2017 Aug; 16(8):1705-1716. PubMed ID: 28716813
[TBL] [Abstract][Full Text] [Related]
12. Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity.
Yang Y; Gorzelanny C; Bauer AT; Halter N; Komljenovic D; Bäuerle T; Borsig L; Roblek M; Schneider SW
Oncogene; 2015 Nov; 34(47):5832-42. PubMed ID: 25745999
[TBL] [Abstract][Full Text] [Related]
13. miRNA-558 promotes tumorigenesis and aggressiveness of neuroblastoma cells through activating the transcription of heparanase.
Qu H; Zheng L; Pu J; Mei H; Xiang X; Zhao X; Li D; Li S; Mao L; Huang K; Tong Q
Hum Mol Genet; 2015 May; 24(9):2539-51. PubMed ID: 25616966
[TBL] [Abstract][Full Text] [Related]
14. Roles of different IRES-dependent FGF2 isoforms in the acquisition of the major aggressive features of human metastatic melanoma.
Andreucci E; Bianchini F; Biagioni A; Del Rosso M; Papucci L; Schiavone N; Magnelli L
J Mol Med (Berl); 2017 Jan; 95(1):97-108. PubMed ID: 27558498
[TBL] [Abstract][Full Text] [Related]
15. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
Marchetti D; McQuillan DJ; Spohn WC; Carson DD; Nicolson GL
Cancer Res; 1996 Jun; 56(12):2856-63. PubMed ID: 8665526
[TBL] [Abstract][Full Text] [Related]
16. Laminin alpha5 chain metastasis- and angiogenesis-inhibiting peptide blocks fibroblast growth factor 2 activity by binding to the heparan sulfate chains of CD44.
Hibino S; Shibuya M; Hoffman MP; Engbring JA; Hossain R; Mochizuki M; Kudoh S; Nomizu M; Kleinman HK
Cancer Res; 2005 Nov; 65(22):10494-501. PubMed ID: 16288042
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between tumor cells and lymphocytes modulates heparanase expression.
Theodoro TR; Matos LL; Cavalheiro RP; Justo GZ; Nader HB; Pinhal MAS
J Transl Med; 2019 Mar; 17(1):103. PubMed ID: 30922347
[TBL] [Abstract][Full Text] [Related]
18. Effects of unfractionated heparin and rivaroxaban on the expression of heparanase and fibroblast growth factor 2 in human osteoblasts.
Xia J; Sheng W; Pei L; Li N; Zhang Z; Wang J; Zu J; Wang N; Wang D
Mol Med Rep; 2017 Jul; 16(1):361-366. PubMed ID: 28498476
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
Marchetti D; Nicolson GL
Adv Enzyme Regul; 1997; 37():111-34. PubMed ID: 9381967
[TBL] [Abstract][Full Text] [Related]
20. Heparanase Promotes Glioma Progression and Is Inversely Correlated with Patient Survival.
Kundu S; Xiong A; Spyrou A; Wicher G; Marinescu VD; Edqvist PD; Zhang L; Essand M; Dimberg A; Smits A; Ilan N; Vlodavsky I; Li JP; Forsberg-Nilsson K
Mol Cancer Res; 2016 Dec; 14(12):1243-1253. PubMed ID: 27565180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]